Center for Breakthrough Medicines plans for an even larger dive into cell therapy manufacturing
As the pipeline for cell therapies grows, manufacturers and CDMOs are looking to get in on the action.
The Center for Breakthrough Medicines, a Pennsylvania-based CDMO, is partnering with Discovery Labs to accelerate plans to build the capacity to manufacture more than 10,000 patient therapies at their headquarters in King of Prussia, PA, a suburb of Philadelphia.
The planning has begun on the manufacturing suites and supporting infrastructure, and when completed the facility, according to CBM’s conservative calculations, the site will be able to produce around 10,000 batches of product per year in the space.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.